Apr 08, 2020 - The FDA stretches the review timeline of Roche's (RHHBY) NDA for risdiplam by three months, which is being evaluated to treat spinal muscular atrophy. A decision is now pending on Aug 24, 2020.
Apr 07, 2020 - The race to introduce a vaccine and drug for COVID-19 is creating near-term opportunities, making the biotech sector a lucrative space for investments.
Apr 07, 2020 - The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck & Co, Novartis, PayPal and IBM
Apr 06, 2020 - Top Stock Reports for J&J, Merck, Novartis & Others
Apr 01, 2020 - NVS vs. NVO: Which Stock Is the Better Value Option?
Mar 31, 2020 - The FDA approves Eli Lilly's (LLY) sBLA for Taltz injection to treat pediatric patients with moderate to severe plaque psoriasis. Stock up.
Mar 30, 2020 - Novartis (NVS) announces pipeline updates on inclisiran and regulatory updates on Cosentyx and Zolgensma.
Mar 30, 2020 - Drug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
Mar 27, 2020 - Criminal charges have been dropped in Nevada against three topless protesters who were arrested at a rally for Democratic presidential hopeful Bernie Sanders in Carson City in February.
Mar 27, 2020 - An old malaria drug may unseat newer investigational coronavirus treatments -- if data is confirmed.